HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fragile X syndrome in Korea: a case series and a review of the literature.

Abstract
The purposes of this study were to present DNA analysis findings of our case series of fragile X syndrome (FXS) based on methylation-specific polymerase chain reaction (MS-PCR), PCR, and Southern blotting alongside developmental characteristics including psychological profiles and to review the literature on FXS in Korea. The reports of 65 children (male:female, 52:13; age, 6.12+/-4.00 yrs) referred for the diagnosis of FXS over a 26-months period were retrospectively reviewed for the identification of full mutation or premutation of fragile X mental retardation 1 (FMR1). Among the 65 children, there were 4 boys with full mutation, and one boy showed premutation of FMR1, yielding a 6.15% positive rate of FXS. All 4 children with full mutation showed significant developmental delay, cognitive dysfunction, and varying degrees of autistic behaviors. The boys with premutation showed also moderate mental retardation, severe drooling, and behavioral problems as severe as the boys with full mutation. Thirteen articles on FXS in Korea have been published since 1993, and they were reviewed. The positive rate of FXS was in the range of 0.77-8.51%, depending on the study groups and the method of diagnosis. Finally, the population-based prevalence study on FXS in Korea is required in the near future.
AuthorsShin-Young Yim, Bo Hyun Jeon, Jung A Yang, Hyon J Kim
JournalJournal of Korean medical science (J Korean Med Sci) Vol. 23 Issue 3 Pg. 470-6 (Jun 2008) ISSN: 1011-8934 [Print] Korea (South)
PMID18583885 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • FMR1 protein, human
  • Fragile X Mental Retardation Protein
Topics
  • Child
  • Child, Preschool
  • Female
  • Fragile X Mental Retardation Protein (genetics)
  • Fragile X Syndrome (diagnosis, epidemiology, genetics)
  • Humans
  • Infant
  • Korea (epidemiology)
  • Male
  • Mutation
  • Prevalence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: